Lung cancer (NSCLC, SCLC)
Therapeutic area: Oncology (C00-D49). All FDA-approved drugs in this category accessible via Reserve Meds's NPP pathway.
Drugs in this condition
- Augtyro
- Emrelis
- Ensacove
- Hernexeos
- Hernexeos As Zongertinib
- Imdelltra
- Jaypirca
- Jascayd
- Krazati
- Leclaza Lazcluze
- Ohtuvayre
- Rybrevant
- Tevimbra
- Voranigo
- Zegfrovy
How to start
Identify the prescribed drug above, then start an intake request.
Related hubs in Oncology
- Multiple myeloma
- Non-Hodgkin lymphoma
- Leukemia (ALL, AML, CLL, CML)
- Myelodysplastic syndrome
- Myelofibrosis
- Breast cancer
- GI cancers (CRC, gastric, HCC, pancreatic)
- GU cancers (prostate, bladder, RCC)
- Gynecologic cancers
- Melanoma and skin cancers
- CNS tumors (glioma, glioblastoma)
- Sarcomas
- Head and neck cancers
- Nasopharyngeal cancer
- Oncology supportive care
- Rare oncology indications